| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-18 21:11 Tx date 2025-11-14 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,642 vol |
60,748 | |
| Filed 2025-05-28 16:30 Tx date 2025-05-27 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+20,338 vol |
59,106 | |
| Filed 2025-05-05 16:42 Tx date 2025-05-01 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+2,210 vol |
38,768 | |
| Filed 2024-08-06 22:05 Tx date 2024-08-02 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+14,696 vol |
36,558 | |
| Filed 2024-07-02 22:30 Tx date 2024-06-28 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,764 vol |
21,862 | |
| Filed 2024-07-02 18:52 Tx date 2024-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$14,929
+2,142 vol $6.97 each |
227,421 | |
| Filed 2024-07-02 18:47 Tx date 2022-05-05 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Robertson, Russel Clark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-11 10:06 Tx date 2016-06-14 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Robertson, Russel Clark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-02 17:32 Tx date 2024-03-29 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,481 vol |
20,098 | |
| Filed 2024-04-01 17:25 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+2,945 vol |
225,279 | |
| Filed 2024-01-03 21:43 Tx date 2023-12-29 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,502 vol |
18,617 | |
| Filed 2024-01-02 17:28 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,245
+3,896 vol $8.02 each |
222,334 | |
| Filed 2023-10-03 21:06 Tx date 2023-09-29 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,511 vol |
17,115 | |
| Filed 2023-10-03 11:30 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,244
+3,801 vol $8.22 each |
218,438 | |
| Filed 2023-07-05 16:15 Tx date 2023-06-30 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,276 vol |
15,604 | |
| Filed 2023-07-04 16:52 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,248
+3,906 vol $8.00 each |
214,637 | |
| Filed 2023-05-23 12:57 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
210,731 | |
| Filed 2023-05-08 09:53 Tx date 2023-05-04 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,857 vol |
14,328 | |
| Filed 2023-04-27 16:06 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-114,567.04
-6,692 vol $17.12 each |
5,808 | |
| Filed 2023-04-27 16:06 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Robertson, Russel Clark
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,000
+12,500 vol $17.12 each |
12,500 |